CD19 and neoplasm: When the tumor volume reached 60–80 mm3, we treated the mice with PBS (as a control), ADR (6 nmol/kg), LDM (2, 4, or 6 nmol/kg), or anti-CD19(Fab)-LDM (2, 4, or 6 nmol/kg).